kapsułki o przedłużonym uwalnianiu clinical trials

SABINE - The efficacy and Safety of delayed-release Budesonide in children with primary IgA nephropathy - a multicenter, interventional phase III, randomized, placebo-controlled, double-blind study.

This study looks at a new way to treat a kidney condition called IgA nephropathy in children. It compares a special medicine (budesonide) with a dummy medicine (placebo) to see if it can help reduce protein in the urine and is safe.